CEOs respect importance of reputation

Share this article:
Healthcare CEOs are concerned about corporate reputation, according to a survey by FischerHealth, Porter Novelli Consulting and PRSA Health Academy.

Nearly two-thirds of the 30 CEOs surveyed said reputation was “critical” or “very important” to their organization's success, and similar numbers said a positive shift in reputation “significantly” or “dramatically” affects their bottom line.

A large majority (86%) said negative events would adversely impact their bottom line.

All rated their firm's reputation as “excellent” to “good” with key external audiences, including consumers, regulators, legislators and employees, though less than half (47%) rated their reputation with news media as “very good.”

However, more than one-third (39%) had not measured their reputation. Three-quarters of respondents said they were “satisfied” or “very satisfied” with their staff's ability to understand and deliver on reputation-management objectives.

Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.